New diabetes clinical trial: Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

Published on: May 07, 2025 at 11:00PM
Conditions: Diabetic Kidney Disease (DKD)
Interventions: Drug: Isuzinaxib; Drug: Placebo
Sponsors: Aptabio Therapeutics, Inc.
Not yet recruiting
https://ift.tt/c0ExdaH